NASDAQ OMX

Zinpro Corporation Launches Zinpro Discovery Foundation

31.5.2017 18:55 | NASDAQ OMX

Dela

Its mission: to discover, research, or develop solutions to improve human and animal wellness

EDEN PRAIRIE, Minn., May 31, 2017 (GLOBE NEWSWIRE) -- Zinpro Corporation has announced the launch of the Zinpro Discovery Foundation, a U.S.-tax-exempt 501(c) (3) nonprofit organization whose mission is to discover, research, or develop solutions to improve human and animal wellness across the globe.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3a52721d-7a4c-4be7-b0bd-7380090f7406

"Zinpro Corporation pioneered the research and development of Performance Minerals® more than 45 years ago," says William Scrimgeour, president and COO. "Over the years, our many nutritional and business solutions have resulted in significant improvements in animal wellness and performance. However, our global leadership in animal mineral nutrition also comes with the responsibility to ensure our research is used to benefit society as much as possible. With this goal in mind, we have collaborated with leaders outside Zinpro to create the Zinpro Discovery Foundation."

Nutritionists have long known that trace mineral nutrition is essential to health for both humans and animals. For example, zinc deficiency negatively affects up to 2 billion people worldwide.1 For so many people across the globe, the difference between being healthy and unhealthy lies in only a few milligrams of zinc. The multiple systemic effects from zinc deficiency include growth retardation, weight loss, infertility, hair loss, mental and emotional disorder, impaired immune function and skin lesions.

Zinc is just one essential trace mineral that shows benefits when supplemented to both animal and human diets. Other essential trace minerals, such as copper, cobalt, manganese, iron, chromium, selenium and iodine, also play key roles that benefit animal and human health.

"Since our research in animal nutrition has great potential to pave the way for breakthroughs in human health, we started a nonprofit organization to make that possible, and the Zinpro Discovery Foundation is the culmination of our efforts," Scrimgeour says.

The Zinpro Discovery Foundation welcomes donations to help raise awareness and knowledge about trace mineral deficiencies and how to improve human and animal wellness. Educational and research grants are allocated by a board of directors. The donation goal for 2017 is $1 million (USD) in educational and research grants.

Grants are available to researchers and organizations through an application process that starts online at zinprodiscoveryfoundation.org. Details of the request include how a researcher or an organization would spend the funds if the grant is received. Requests are evaluated based on the applicant's stated problem statements and project goals.

To obtain additional information, including regular updates on active grants and recent donations, check online at zinprodiscoveryfoundation.org.

1. Data are based on the composite nutrient composition database, IZINCG physiological requirements and the Miller Equation to estimate zinc absorption and an assumed 25% inter-individual variation in zinc intake. Data are for the 2005 time frame (2003-2007). To confirm the prevalence of zinc deficiency, it is recommended to assess plasma zinc concentration and/or dietary zinc intake in countries identified at high risk of zinc deficiency based on a high stunting prevalence or high prevalence of dietary zinc availability (http://www.izincg.org/).

About Zinpro Corporation

More than 45 years ago, Zinpro Corporation pioneered the research and development of Performance Minerals®. As a family-owned, privately-held company, Zinpro Corporation's steady growth has come as a result of quality products, quality people and a focus on one thing: performance trace minerals for exceptional animal nutrition. Today, the company has regional sales offices located in nine countries and markets its products in more than 70 countries worldwide. For more information, visit  zinpro.com , or call +1 952-983-4000.

Performance Minerals® is a registered trademark of Zinpro Corporation. ©2017 Zinpro Corp. All rights reserved.

For more information, contact:
John Pocock
Corporate Communications Specialist
Zinpro Corporation
+1 952-983-3937
jpocock@zinpro.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Zinpro Corporation via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste nyheterna från NASDAQ OMX

Scientific breakthrough on objective diagnosis of PTSD26.6.2017 16:51Pressmeddelande

Scientific breakthrough for non-invasive, automatic, objective diagnosis of PTSD leveraging autonomic biomarkers Accuracy of 80% (+/- 1%) for objectively diagnosing subjects with PTSD Medibio has exclusive worldwide rights to commercialise the technology SYDNEY, Australia and MINNEAPOLIS, June 26, 2017 (GLOBE NEWSWIRE) -- Australian Stock Exchange-listed medical technology company Medibio Limited (MEB or the Company) announces a new research study, conducted at Emory University, Atlanta GA and funded by Medibio, demonstrates that post-traumatic stress disorder (PTSD) can be accurately diagnosed using a non-invasive protocol involving heart rate data and machine learning algorithms. The research was based on technology developed at Emory University and licensed by Medibio. The research is described in a paper titled "Classification of post-traumatic stress disorder from heart rate vari

Informa's Annual Clinical and Research Excellence Awards Return for Third Year26.6.2017 16:48Pressmeddelande

BOSTON, June 26, 2017 (GLOBE NEWSWIRE) -- Informa's Pharma Intelligence has today announced that the third annual Clinical and Research Excellence (CARE) Awards are now open for nominations. Pharma Intelligence - the world's leading provider of clinical and research intelligence and analysis, and home of leading brands such as Scrip, Pink Sheet and Biomedtracker - will host the awards which recognize and celebrate outstanding achievements and stand-out performers in the global R&D space. Nominations for the CARE Awards are free and all submissions should be made via the online entry form available at www.clinicalresearchexcellence.com by December 23. All entries will be assessed by a panel of distinguished industry experts and the winners will be announced at the CARE Awards ceremony on April 25, 2018 at the Boston Harbor Hotel. "The success of last year's CARE Awards was testament to the original mission of the CARE Awards: to recognize the ex

Forterra Announces Definitive Agreement with Thompson Pipe Group26.6.2017 14:00Pressmeddelande

Thompson Pipe Group to Acquire Forterra's U.S. Concrete and Steel Pressure Pipe Assets Forterra to Acquire Thompson Pipe's Drainage Pipe & Products Manufacturing Facility with a Strategic Position in Houston Market IRVING, Texas, June 26, 2017 (GLOBE NEWSWIRE) -- Forterra, Inc. ("Forterra" or the "Company") (Nasdaq:FRTA), a leading manufacturer of water infrastructure pipe and products in the United States and Eastern Canada, today announced it has entered into a definitive agreement to sell the U.S. concrete and steel pressure pipe assets of its Water Pipe and Products business segment to Thompson Pipe Group. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2017.  Under the terms of the agreement, an affiliate of Thompson Pipe Group will acquire assets related to five Forterra manufacturing facilities and a fittings facility. Forterra will receive approximate

Nasdaq Closing Cross Calculates Russell US Indexes Reconstitution for the 14th Consecutive Year24.6.2017 01:52Pressmeddelande

A new record $28.9 billion traded at the closing cross in a Russell reconstitution NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- Nasdaq (Symbol: NDAQ) today announced the Nasdaq Closing Cross was used for the 14th consecutive year to rebalance Nasdaq-listed securities in the entire family of  Russell US Indexes, part of leading global index provider FTSE Russell, during its annual reconstitution. More than 972 million shares representing a record $28.9 billion were executed in the Nasdaq Closing Cross in 0.861 seconds across some 2,499 Nasdaq-listed stocks. The previous record for dollars traded at the closing cross in a Russell reconstitution was $21.1 billion in 2015. "For the 14th consecutive year of partnering with FTSE Russell on the rebalance, we witnessed the advanced capabilities and market integrity of Nasdaq's INET technology platform resulting in transparent and efficient price discovery which benefits issuers and investors alike,&quot

LifeSci Advisors' Board Placement Initiative Announces Ninth Board Placement23.6.2017 17:52Pressmeddelande

NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, a leading life sciences-focused investor relations consultancy, announced today the ninth placement of a female executive to a life sciences company board as part of their Board Placement Initiative (BPI), a program launched a year ago with the goal to connect female executives in the life sciences industry with companies looking for board candidates. LifeSci is pleased to share news of the appointment of Jean M. Franchi to the Board of Directors of Biophytis, a biotech company listed on Euronext Paris (ALBPS) focused on drugs that target diseases of aging, with drug candidates in clinical development for dry AMD and Sarcopenia. "I'm honored to join the Biophytis board, and look forward to helping the company achieve a more global presence as it advances its portfolio of innovative therapies addressing unmet needs associated with aging," said Ms. Franchi. "I want to extend my kind thanks to LifeSci

Fentress Architects Announces its Annual Student Global Challenge23.6.2017 09:00Pressmeddelande

6th edition invites students to re-envision the terminal building in the year 2075 Denver, Colorado, June 23, 2017 (GLOBE NEWSWIRE) -- Fentress Architects, based in Denver, Colorado, announces the 2017 Fentress Global Challenge, an international design competition for young and student architects. As in years past, the theme, consistent with the firm's expertise in airport design and aviation, is envisioning an airport of the future.  Participants are encouraged to re-envision the terminal building in the year 2075 using one of 10 existing international airports, taking into consideration local context, technological trends, and project feasibility and passenger experience. This is the sixth year that Fentress Architects has sponsored and administered the award, which brings a First Prize of $15,000 and a summer internship at Fentress' Denver office; four additional winners will receive smaller cash awards.

I vårt nyhetsrum kan du läsa de senaste nyheterna, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt nyhetsrum